Neko Health Raises $700 Million to Expand Its Prevention Platform

The Swedish health tech company Neko Health has closed a Series C funding round of $700 million. The round was led by Lightspeed Venture Partners and co-led by O.G. Venture Partners. The company plans to use the new capital to accelerate its expansion into the U.S. and open additional locations for its technology-based health checkups.

Neko Health was founded by Spotify co-founder Daniel Ek and Hjalmar Nilsonne and is developing a new model for preventive healthcare. At its core is a 60-minute, non-invasive full-body scan that collects millions of health data points and evaluates them immediately with a doctor. The goal is to detect diseases as early as possible and to place greater emphasis on prevention in medical care.

$700 million for international expansion

In addition to existing investors Atomico, General Catalyst, and Lakestar, Liberty City Ventures, Positive Sum, and BDT & MSD, among others, participated in the funding round. In addition, numerous prominent figures invested, including Mark Zuckerberg and Priscilla Chan, Maria Sharapova, Thierry Henry, Tim Ferriss, will.i.am, Claudia Schiffer, and Jimmy Iovine.

The funding is intended, in particular, to accelerate the company’s market entry in the U.S. Neko plans to open its first clinics in New York later this year and subsequently expand to other U.S. locations.

More than 350,000 people on the waiting list

Since its launch in 2023, Neko Health has continuously expanded its presence in Sweden and the United Kingdom. To date, more than 100,000 people have undergone a Neko Health Scan, while over 350,000 interested individuals have joined the waiting list.

According to the company, 75 percent of customers book their next health checkup for the following year immediately after their first appointment.

Prevention Instead of Disease Treatment

The latest funding round follows extensive further development of the platform. New features, such as the integration of wearables and body composition analysis, further enhance the health check. According to the company, initial long-term evaluations are already showing measurable success: Three out of four members who were previously diagnosed with serious or life-threatening conditions have since stabilized their health or brought their condition under control.

With this record funding, Neko Health ranks among the most heavily funded European health tech companies and underscores the growing trend toward data-driven preventive medicine.